Vaccines, blood, antisera, toxins and cultures in   Ireland

Exports In 2022, Ireland exported $47.3B in Vaccines, blood, antisera, toxins and cultures, making it the 1st largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 1st most exported product in Ireland. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Ireland are: United States ($17.8B), Belgium ($9.85B), Germany ($4.59B), China ($3.39B), and Switzerland ($2.5B).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Ireland between 2021 and 2022 were Belgium ($3.91B), Netherlands ($1.98B), and United States ($1.56B).

Imports In 2022, Ireland imported $5.04B in Vaccines, blood, antisera, toxins and cultures, becoming the 15th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 5th most imported product in Ireland. Ireland imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($2.3B), Spain ($639M), Germany ($584M), France ($344M), and Belgium ($285M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Ireland between 2021 and 2022 were Spain ($172M), France ($85.6M), and Germany ($68.5M).